Overview

Phase 2a Study of IW-6463 in Adults Diagnosed With MELAS

Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This is a single-arm study to evaluate safety and tolerability of oral IW-6463 in adults diagnosed with MELAS
Phase:
Phase 2
Details
Lead Sponsor:
Cyclerion Therapeutics
Collaborator:
Children's Hospital of Philadelphia